Navigation Links
Dirty Drugs and We Know It: Attorneys at Console & Hollawell Comment on ISMP Survey Relating to Contaminated Drug Compounds and the Risks to Consumers

Marlton, NJ (PRWEB) February 08, 2013

Many supposed ‘sterile’ drugs are often contaminated, according to a new survey of hospital pharmacists conducted by the Institute for Safe Medication Practices (ISMP). The report, highlighted in a recent article by NBC News, says 13 percent of pharmacists and pharmacy technicians believe contamination of compounded sterile drugs occurred in their shops in 2012. These are the same class of medications that reportedly caused the deaths of 45 people across the country and led to 700 infections from fungal meningitis. In New Jersey, where more than a dozen patients died after receiving injections of tainted steroid compound, personal injury attorney Richard P. Console Jr. sees the potential for another serious outbreak.

“Compromised facilities are endangering the lives of patients everywhere,” he said. “The Food and Drug Administration needs to step up inspections and enforcement actions to prevent the next New England Compounding Center from distributing a batch of infected product. These compounds are supposed to help people, not put their lives in jeopardy.”

The majority of pharmacists surveyed had little to no confidence that contamination at their facilities were completely free of contamination during the year, according to NBC News. Almost 75 percent of all healthcare professionals participating in the ISMP study reportedly said conditions for the contamination of sterile drug compounds could exist at their sites. Compounding centers have come under increasing fire in the last year after conditions at facilities owned by the New England Compounding Center lead to a nationwide fungal meningitis outbreak. The company has since shuttered its doors.

Compounding centers take existing medications from actual pharmaceutical manufacturers and combine them to create new materials. While the Food and Drug Administration (FDA) does not regulate these centers as it does pharmaceutical manufacturers, the federal government has moved to inspect their facilities more closely in light of the widespread meningitis infections. This move overlays current inspection and regulation duties, which state authorities are supposed to handle. Console, whose firm has represented more than 5,000 clients, doesn’t believe the measures go far enough to protect consumers.

“If we were doing enough to protect patients from harm, we wouldn’t have pharmacists and doctors saying sterile medications are still being contaminated,” he said. “Aggressive pursuit of compounding centers that sell contaminated drugs and allow deplorable conditions to exist at their facilities is necessary to curtail the behavior. The victims and their families deserve compensation. Civil suits are sometimes the only way to make these industries change their ways.”

Richard P. Console Jr. managing partner of Console & Hollawell P.C., has been a personal injury lawyer in New Jersey since 1994. His firm has obtained more than $30,000,000 in compensation for injured victims, including those who have suffered due to the actions of negligence manufacturers and healthcare providers.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dirty Pacifiers May Make Infants Sick: Study
2. No Evidence That Lupus Drugs Lead to Cancer, Says Study
3. Glazer receives grant to study light-activated cancer drugs
4. Hops, Key to Flavor in Beer, May Prove Useful in New Drugs
5. No Proof Drugs Ease Kids Migraines: Study
6. FDA Approves 3 New Drugs for Type 2 Diabetes
7. Do non-steroidal anti-inflammatory drugs cause kidney failure in children?
8. Research: Lupus drugs carry no significant cancer risk for patients
9. Hearing-loss-prevention drugs closer to reality thanks to new UF test
10. Scientists find a new way to boost common cancer drugs
11. UGA discovery promises to improve drugs used to fight cancer, other diseases
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... It takes only ... a business, it is critical that the first impression be positive and reflects business ... not likely to buy anything or want to return. They will also share their ...
(Date:11/24/2015)... ... 24, 2015 , ... United Benefit Advisors (UBA), the nation’s ... as its newest Partner Firm. Based in Jefferson City, Missouri, their core philosophy ... regardless of whether that client is a business, a family, or an individual. ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Serenity Point Rehabilitation, ... series of recent video interviews with some of the staff members at their recovery ... residential treatment facility, as well as some of the things that make their recovery ...
(Date:11/24/2015)... ... 2015 , ... Abington Hospital – Jefferson Health is pleased ... Surgery Facility for treating individuals living with morbid or extreme obesity. , Aetna ... its members to help them make informed decisions about their healthcare needs. In ...
(Date:11/24/2015)... ... November 24, 2015 , ... American Specialty ... Program have announced their endorsement of the Medical Fitness Network (MFN), a ... proud to have the MFN as one of our endorsed organizations,” said ASH ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015 iRhythm Technologies, Inc. , a ... today announced that it will participate in the 27th Annual Piper ... New York, NY . Kevin King , ... December 1, 2015 at 8:50am ET. --> ... . --> . --> iRhythm ...
(Date:11/24/2015)... Ontario , Nov. 24, 2015 Teledyne ... digital X-Ray image sensing technology, will introduce its CMOS ... Technical Exhibition , November 29 to December 3, at McCormick ... of dynamic detectors for diagnostic and interventional imaging will be ... Xineos family of advanced CMOS X-Ray detectors is ...
(Date:11/24/2015)... The uptake of recently approved and pipeline premium products for ... growth to 2021, says GBI Research . ... Type 1 Diabetes Mellitus (T1DM), will be a key driver of market ... --> The uptake of recently approved and pipeline premium products ... market growth to 2021, says GBI Research . ...
Breaking Medicine Technology: